🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementThe nausea is gone at month 3 - there IS a light at the end Page 5

The nausea is gone at month 3 - there IS a light at the end

tampaLisa73 Mon, Apr 6, 2026 at 3:07 AM 29 replies 852 viewsPage 5 of 6
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Apr 15, 2026 at 3:06 AM#21

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Apr 15, 2026 at 7:06 AM
20 18jim_asheville, matt_MKE, Dr.ReproEndo and 17 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Apr 15, 2026 at 11:06 PM#22
Dr.EM_Chicago said:
It helps to say which part of this you are uncertain about.

Same experience, arrived at from the opposite direction. Posting only so the count is not one.

Last edited: Apr 16, 2026 at 4:06 AM
21 19raj_cambridge, ingrid_STO, pete_nash and 18 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Apr 16, 2026 at 7:06 PM#23
Dr.EM_Chicago said:
It helps to say which part of this you are uncertain about.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

22 20MikeNYC_runner and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Apr 17, 2026 at 3:06 PM#24

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

23 21bri_stats, pete_manc_UK, anna.melb_AU and 20 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Apr 18, 2026 at 11:07 AM#25

One thing that is still open after Dr.EM_Chicago’s answer:

What would you measure differently if you were starting again?

24 22amsterdam_pete, LondonLisa, mike_nyc and 21 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register